FDA decision: Ulixacaltamide by Praxis Precision Medicines (on or before January 29, 2027)

FDA decision on Ulixacaltamide on or before January 29, 2027 If the FDA's decision on Ulixacaltamide by Praxis Precision Medicines on or before January 29, 2027 is a full approval or an accelerated approval, the market resolves to Yes. This market will resolve to No if the FDA's decision is a denial (CRL issued), a withdrawal by the sponsor, or a conditional approval — or if no decision is issued. This market will close early if the FDA issues a decision on Ulixacaltamide before Jan 30, 2027